Molecular Partners AG
- MOLN
- NASDAQ
- Biotechnology
- DARPin Protein Therapeutics
- Biopharmaceutical R&D
$3.56
Today −2.47%Quote Oct 16, 2026, 08:00 PM UTC
−14.93%over the last month
Max drawdown −17.2%From 1-month high −17.2%3 months −11.0%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Market value
$136.4M
Quote Oct 16
Next earnings
Oct 29
Expected, not confirmed
Analyst target
$21.00
+489.9% from here
Floor
$3.55
0.3% below price
Where the price sits
4 analysts
Analyst range, low to high
$13.00$29.00
- Price $3.56
- Resistance $3.83
- Consensus $21.00
The price is just above its floor. Analysts' average target sits about 490% higher. Their range is wide.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about MOLNPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days freeWhere the money comes from
No revenue split by segment on file.
Industry
Biotechnology
Employees
134
Founded
2004